3,402
Views
10
CrossRef citations to date
0
Altmetric
Research Paper

Empagliflozin protects diabetic pancreatic tissue from damage by inhibiting the activation of the NLRP3/caspase-1/GSDMD pathway in pancreatic β cells: in vitro and in vivo studies

, ORCID Icon, , , &
Pages 9356-9366 | Received 20 Aug 2021, Accepted 28 Oct 2021, Published online: 25 Nov 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.